科创板第五套标准重启后首家创新医疗器械IPO受理 获多家资深专业机构投资者投资

Core Viewpoint - Shenzhen Core Medical Technology Co., Ltd. has successfully had its IPO application accepted by the Shanghai Stock Exchange, marking it as the first innovative medical device company to be accepted under the new fifth set of listing standards for the Sci-Tech Innovation Board [1] Company Summary - Core Medical has received investments from multiple seasoned professional institutional investors, including Zhuhai Hillhouse Private Equity Fund Management Co., Ltd. and Shanghai Zhengxin Valley Investment Management Co., Ltd. [1] - This acceptance follows the case of Zhuhai Tainuo Maibo Pharmaceutical Co., Ltd., making Core Medical the second company to recognize seasoned professional institutional investors in its Sci-Tech Innovation Board application [1] Industry Summary - The acceptance of Core Medical's IPO application is seen as a practical implementation of the "Sci-Tech-Capital" dual circulation in the innovative medical device sector [1] - It highlights the clear direction of the Sci-Tech Innovation Board in providing essential capital market support for high-quality technology enterprises that have significant R&D investments and long profit cycles [1]